RELMADA THERAPEUTICS, INC. — Form 8-K
Filed September 8, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Relmada Therapeutics filed an 8-K on 2026-09-08 reporting Item 8.01 (Other Events) for the period ending 2026-09-03. The actual substance of the event is not disclosed in the filing header or XBRL schema/label files provided; the document text itself is not included in this submission extract, only metadata and file references.
Why this rating
Cannot assess significance without event details. 8-K metadata alone is routine. No dollar amounts, counterparties, or material facts disclosed here.
Extracted items
See more from September 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.